Judge Won't Nix $327M Verdict Over J&J's Risperdal
By Erin Fuchs ( December 21, 2011, 1:00 PM EST) -- A South Carolina judge refused Tuesday to overturn a jury's $327 million verdict in the Palmetto State's suit accusing a Johnson & Johnson unit of downplaying ties between its antipsychotic drug Risperdal and diabetes....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.